Common use of PROPERTY RIGHTS IN AND TO THE TECHNOLOGY Clause in Contracts

PROPERTY RIGHTS IN AND TO THE TECHNOLOGY. 2.1. The parties hereto hereby acknowledge and agree that: (a) Dr. Xxxxxxx Xxxxxx has assigned his rights to the Technology and any Improvements to the University; (b) the University owns any and all right, title and interest in and to the technology identified in UBC Invention Disclosure File # UBC 94-061, entitled “Lipolipase Mutation 291, Implication for Coronary Artery Disease”, and File # UBC 91-003, entitled “Mutation in Human Lipoprotein Lipase Gene which causes Type 1 Hyperlipoproteinemia” as well as any and all UBC Improvements (the “UBC Technology”); (c) [**] has developed or acquired certain technology which has common subject matter with certain technology invented, developed and/or acquired by the University, and the University and [**] are named as joint owners within the United States of the technology identified in UBC Invention Disclosure File # UBC 99-082, entitled “Recombinant Viruses Preparation and use thereof in Gene Therapy” (the “UBC -[**] Technology”); (d) the University and AMC jointly own the technology identified in UBC Invention Disclosure File # UBC 00-039, entitled “Mutation 447” (the “UBC - Amsterdam Technology”), (e) the University and the Licensee, subject to the terms of this Agreement jointly own all Joint Improvements, and provided that notwithstanding the applicable patent or other intellectual property laws of any jurisdiction both the University and the Licensee shall only use and commercially exploit any Joint Improvements in accordance with the terms of this Agreement; and (f) the Licensee, subject to the terms of this Agreement, owns any all right, title and interest in and to the Xenon Improvements. 2.2. The Parties shall, on request, enter into such further agreements and execute any and all documents as may be required to ensure that ownership of the Technology, and any Improvements vest with, or remain with, the parties as set out in Article 2.1.

PROPERTY RIGHTS IN AND TO THE TECHNOLOGY. 2.1. 2.1 The parties hereto hereby acknowledge and agree that: (a) Dr. Xxxxxxx Xxxxxx has assigned his rights to the Technology and any Improvements to the University; (b) the University owns any and all right, title and interest in and to the technology identified in UBC Invention Disclosure File # UBC 94-061, entitled “Lipolipase Mutation 291, Implication for Coronary Artery Disease”, and File # UBC 91-003, entitled “Mutation in Human Lipoprotein Lipase Gene which causes Type 1 Hyperlipoproteinemia” as well as any and all UBC Improvements (the “UBC Technology”); (c) [**†] has developed or acquired certain technology which has common subject matter with certain technology invented, developed and/or acquired by the University, and the University and [**†] are named as joint owners within the United States of the technology identified in UBC Invention Disclosure File # UBC 99-082, entitled “Recombinant Viruses Preparation and use thereof in Gene Therapy” (the “UBC -– [**†] Technology”); (d) the University and AMC jointly own the technology identified in UBC Invention Disclosure File # UBC 00-039, entitled “Mutation 447” (the “UBC - UBC—Amsterdam Technology”), (e) the University and the Licensee, subject to the terms of this Agreement jointly own all Joint Improvements, and provided that notwithstanding the applicable patent or other intellectual property laws of any jurisdiction both the University and the Licensee shall only use and commercially exploit any Joint Improvements in accordance with the terms of this Agreement; and (f) the Licensee, subject to the terms of this Agreement, owns any all right, title and interest in and to the Xenon Improvements.. [†] DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION 2.2. 2.2 The Parties shall, on request, enter into such further agreements and execute any and all documents as may be required to ensure that ownership of the Technology, and any Improvements vest with, or remain with, the parties as set out in Article 2.1.

PROPERTY RIGHTS IN AND TO THE TECHNOLOGY. 2.1. 2.1 The parties hereto hereby acknowledge and agree that: (a) Dr. Xxxxxxx Xxxxxx has assigned his rights to the Technology and any Improvements to the University; (b) the University owns any and all right, title and interest in and to the technology identified in UBC Invention Disclosure File # UBC 94-061, entitled “Lipolipase Mutation 291, Implication for Coronary Artery Disease”, and File # UBC 91-003, entitled “Mutation in Human Lipoprotein Lipase Gene which causes Type 1 Hyperlipoproteinemia” as well as any and all UBC Improvements (the “UBC Technology”);to: (ci) [**] has developed or acquired certain technology which has common subject matter with certain technology the Technology that was conceived, invented, developed and/or acquired solely by the University, and the University and [**] are named as joint owners within the United States of the technology identified in UBC Invention Disclosure File # UBC 99-082, entitled “Recombinant Viruses Preparation and use thereof in Gene Therapy” (the “UBC -[**] Technology”)Personnel; (dii) the University and AMC jointly own the technology identified in any UBC Invention Disclosure File # Improvements that are conceived, invented, developed and/or acquired solely by UBC 00-039, entitled “Mutation 447” (the “UBC - Amsterdam Technology”), (e) the University and the Licensee, subject to the terms of this Agreement jointly own all Joint Improvements, and provided that notwithstanding the applicable patent or other intellectual property laws of any jurisdiction both the University and the Licensee shall only use and commercially exploit any Joint Improvements in accordance with the terms of this AgreementPersonnel; and (fiii) any UBC New Technology; (b) the Licensee, subject to the terms of this Agreement, owns Licensee shall own any and all right, title and interest in and to to: (i) the Xenon QLT Improvements; and (ii) the QLT New Technology. 2.2. (c) the University and the Licensee shall jointly own any and all right, title and interest in and to: (i) the Technology that was conceived, invented, developed and/or acquired jointly by UBC Personnel and the Licensee; and (ii) any UBC Improvements that are conceived, invented, developed and/or acquired jointly by UBC Personnel and the Licensee. 2.2 The Parties shall, on request, parties shall enter into such further agreements and execute any and all documents as may be required to ensure that ownership of the Technology, any Improvements, UBC New Technology, and any Improvements QLT New Technology vest with, or remain remains with, the parties as set out in Article 2.1. 2.3 Not less than once per year during each and every year of the term of this Agreement, the parties shall exchange in writing the details of any and all Improvements which the University or the Licensee have developed and/or acquired during the previous twelve month period. ** Confidential Treatment Requested.

PROPERTY RIGHTS IN AND TO THE TECHNOLOGY. 2.1. The parties hereto hereby acknowledge and agree that: (a) Dr. Xxxxxxx Xxxxxx has assigned his rights to the Technology and any Improvements to the University; (b) the University owns any and all right, title and interest in and to the technology identified in UBC Invention Disclosure File # UBC 94-061, entitled “Lipolipase Mutation 291, Implication for Coronary Artery Disease”, and File # UBC 91-003, entitled “Mutation in Human Lipoprotein Lipase Gene which causes Type 1 Hyperlipoproteinemia” as well as any and all UBC Improvements (the “UBC Technology”); (c) [**†] has developed or acquired certain technology which has common subject matter with certain technology invented, developed and/or acquired by the University, and the University and [**†] are named as joint owners within the United States of the technology identified in UBC Invention Disclosure File # UBC 99-082, entitled “Recombinant Viruses Preparation and use thereof in Gene Therapy” (the “UBC -[**-[†] Technology”); (d) the University and AMC jointly own the technology identified in UBC Invention Disclosure File # UBC 00-039, entitled “Mutation 447” (the “UBC - Amsterdam Technology”), (e) the University and the Licensee, subject to the terms of this Agreement jointly own all Joint Improvements, and provided that notwithstanding the applicable patent or other intellectual property laws of any jurisdiction both the University and the Licensee shall only use and commercially exploit any Joint Improvements in accordance with the terms of this Agreement; and (f) the Licensee, subject to the terms of this Agreement, owns any all right, title and interest in and to the Xenon Improvements. 2.2. The Parties shall, on request, enter into such further agreements and execute any and all documents as may be required to ensure that ownership of the Technology, and any Improvements vest with, or remain with, the parties as set out in Article 2.1.